Riemann J F
Fortschr Med. 1981 Feb 5;99(5):129-33.
Causal therapy of Crohn's disease up to now cannot be achieved due to the unknown etiology. However, randomized multicenter cooperative trials have demonstrated that adrenocorticoids and sulfasalazine are the most efficient basic therapeutics. In the acute attack additional supportive measures like hyperalimentation, transfusions or substitution of vitamins may become necessary. In contrast to former times a maintenance treatment is no longer justified. About 60% of all patients with Crohn's disease have to be operated because of complications of their disease. The knowledge of absolute and relative indications for surgery in Crohn's disease facilitates the decision. Therapy in Crohn's disease has to be differentiated in relation to severity of the disease and disease location.
由于病因不明,目前无法对克罗恩病进行病因治疗。然而,随机多中心合作试验表明,肾上腺皮质激素和柳氮磺胺吡啶是最有效的基础治疗药物。在急性发作期,可能需要采取额外的支持措施,如胃肠外营养、输血或补充维生素。与过去不同,维持治疗已不再合理。所有克罗恩病患者中约60%因疾病并发症而必须接受手术。了解克罗恩病手术的绝对和相对指征有助于做出决策。克罗恩病的治疗必须根据疾病的严重程度和部位进行区分。